- Home
- CNMD
CNMD
CONMED Corporation
as 07-26-2024 4:00pm EST
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Upcoming Earnings Alert:
Get ready for potential market movements as CONMED Corporation CNMD prepares to release earnings report on 31 Jul 2024.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | LARGO |
| Market Cap: | 2.1B | IPO Year: | 1987 |
| Target Price: | $101.71 | AVG Volume (30 days): | 408.3K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $61.05 - $121.11 | Next Earning Date: | 07-31-2024 |
| Revenue: | $1,261,548,000 | Revenue Growth: | 14.83% |
| Revenue Growth (this year): | 8.86% | Revenue Growth (next year): | 8.12% |
Stock Insider Trading Activity of CONMED Corporation (CNMD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Peters Stanley W III | CNMD | President AS and AET | Jun 14 '24 | Sell | $71.82 | 4,000 | $287,280.00 | 63 | SEC Form 4 |
| BRONSON DAVID M | CNMD | Director | May 13 '24 | Buy | $72.09 | 1,350 | $97,321.50 | 16,460 | SEC Form 4 |
| Schwarzentraub Barbara J | CNMD | Director | May 8 '24 | Buy | $69.26 | 1,442 | $99,872.92 | 1,442 | SEC Form 4 |
| Aronson Martha Goldberg | CNMD | Director | May 6 '24 | Buy | $70.98 | 2,000 | $141,960.00 | 2,000 | SEC Form 4 |
| Beyer Pat | CNMD | Chief Operating Officer | Apr 30 '24 | Buy | $68.30 | 3,000 | $204,900.00 | 10,807 | SEC Form 4 |
| Peters Stanley W III | CNMD | President AS and AET | Dec 4 '23 | Sell | $109.93 | 2,300 | $252,833.48 | 63 | SEC Form 4 |
Latest CONMED Corporation News
CNMD Breaking Stock News: Dive into CNMD Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Needham Trims Price Target on CONMED to $106 From $107, Keeps Buy Rating
Zacks
2 days ago
Conmed (CNMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Simply Wall St.
3 days ago
What Does CONMED Corporation's (NYSE:CNMD) Share Price Indicate?
Argus Research
3 days ago
CNMD: What does Argus have to say about CNMD?
Argus Research
10 days ago
CNMD: Raising target price to $77.00
Argus Research
17 days ago
CNMD: Raising target price to $67.00
Business Wire
18 days ago
CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024
Simply Wall St.
a month ago
A Note On CONMED Corporation's (NYSE:CNMD) ROE and Debt To Equity
Compare CNMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CNMD CONMED Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.